Progestogen only pill (POP) for contraception

Provenance

Written by SPS and the College of Sexual and Reproductive Health (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.

August 2025 – note the Faculty of Sexual and Reproductive Healthcare (FSRH) has now changed its name to the College of Sexual and Reproductive Healthcare (CoSRH). Some web pages and CoSRH documents will continue to display the FSRH name; where you see FSRH, this refers to CoSRH. All weblinks are still active.

Planned Review

Following the December 2025 launch of revised UKMEC guidelines from CoSRH, all reproductive health PGDs are being reviewed to ensure they reflect the updated UKMEC.

Updated versions will be published once approved through the SPS governance process, with an expected publication date of end January 2026.

Template versions available

Version 3.0 of this PGD template, valid from April 2026, has been published to allow organisations to undertake local governance processes in a timely manner.

Version 2.3 of this PGD template remains currently valid and will be removed from this page on its expiry (31^st March 2026)

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice.

• POP National PGD template FINAL V2.3 July 25Opens in a new window · Word · 65 KB
• POP National PGD template V3.0 accessible 10.25Opens in a new window · Word · 80 KB

More reproductive health PGD templates

• Combined hormonal contraceptive vaginal ring
• Levonorgestrel 1500 microgram tablets for emergency contraception
• Ulipristal acetate 30mg tablets for emergency contraception
• Combined oral hormonal contraceptive (COC) in reproductive health
• Combined hormonal contraceptive transdermal patch
• Copper Intrauterine Device (Cu-IUD)
• Lidocaine 10mg/ml spray for IUD insertion or removal
• Lidocaine plus prilocaine cream for IUD insertion or removal
• Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
• Medroxyprogesterone acetate (SC-DMPA) injection for contraception
• Medroxyprogesterone acetate (DMPA) IM injection for contraception
• Etonogestrel (e.g. Nexplanon®) implant for contraception
• Lidocaine injection for subdermal etonogestrel in contraception

All PGD templates

Update history